Screener
Recursion Pharmaceuticals, Inc. RXRX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill | 160,350 | 162,158 |
| Deferred tax assets | 957 | 957 |
| Other assets, non-current | 12,186 | 12,754 |
| Total assets | $1,212,668 | $1,474,130 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $12,672 | $18,118 |
| Accrued expenses and other liabilities | 56,936 | 70,230 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s total assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total assets of $1.21B in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total assets decreased by 6.9% year-over-year, from $1.3B to $1.21B.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total assets has grown at a 37.6% compound annual growth rate (CAGR), from $298.59M to $1.47B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Recursion Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude